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Abstract
Background: Falls are the leading cause of unintentional injury and injury-related death among older people. In
addition to physical activity, vitamin D also may affect balance and neuromuscular function. Low serum 25-
hydroksivitamin D level increases the risk of bone loss, falls and fractures. Thus, an appropriate exercise program
and sufficient vitamin D intake may significantly improve not only functional balance, but also balance confidence.
Balance represents a complex motor skill determined by reaction time, muscle strength, and speed and
coordination of movement.
Methods/Design: A 2-year randomized double-blind placebo-controlled vitamin D and open exercise trial of 409
home-dwelling women 70 to 80 years of age comprising four study arms: 1) exercise + vitamin D (800 IU/d), 2)
exercise + placebo, 3) no exercise + vitamin D (800 IU/d), 4) no exercise + placebo. In addition to monthly fall
diaries, general health status, life style, bone health, physical functioning, and vitamin D metabolism will be
assessed. The primary outcomes are the rate of falls and fall-related injuries. Secondary outcomes include changes
in neuromuscular functioning (e.g. body balance, muscle strength), ADL- and mobility functions, bone density and
structure, cardiovascular risk factors, quality of life and fear of falling.
Discussion: The successful completion of this trial will provide evidence on the effectiveness of exercise and
vitamin D for falls reduction.
Trial Registration: ClinicalTrial.gov -register (NCT00986466).
Keywords: Exercise, Falls, Physical functioning, Vitamin D, Mobility function, Neuromuscular functioning, Quality of
life
Background
The rising population of the elderly over the next few
decades will be accompanied by an increase in the num-
ber of people with disease and chronic illness. Older
people are less resistant to injury, whether from physio-
logical events (e.g. heart attack) or environmental
trauma (e.g. bone fracture), as well as to infection [1].
Health maintenance for aging people over their life span
through exercise and proper nutrition contribute to life-
long wellbeing [2].
Osteoporosis, with the main outcome problem of frac-
tures, is a multifactorial disease characterized by low
bone mineral density (BMD) and decreased bone
strength. Often these people also have neuromuscular
deficiencies resulting in an increased risk of falling. Falls
are the leading cause of unintentional injury and injury-
related death among older adults. Approximately 30% of
community living people aged 65 years or older fall
every year the rate being clearly higher in institutions.
Although less than one fall out of 10 results in a frac-
ture, 20% of fall incidents require admissions to hospital
[3-5]. Since the propensity to fall increases the risk of
fracture and other injuries considerably, falls prevention
is widely considered to be the most essential element
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when planning effective injury and fracture prevention
programs for the elderly population [3,6-8].
Preventing falls and injuries among older adults is
challenging. However, there is strong high-quality evi-
dence from randomized controlled trials and subsequent
systematic reviews and meta-analyses that regular
strength and balance training for elderly adults living in
the community can reduce the risk of both noninjurious
and injurious falls by 15-50% [3,7,9,10]. Randomized
controlled trials indicate that not only individually tai-
lored training but also untargeted group exercise pro-
grams are effective in preventing falls [11-14],
particularly if the training program includes Tai Chi or
other exercises which challenge balance [14-16] and
improve lower limb muscle strength [8,10]. Thus, it
seems prudent to recommend regular weight-bearing
and other exercises for community-dwelling older
adults, not only to maintain their musculoskeletal
health, but also to help them stay safely on their feet
[17-19].
Hypovitaminosis D is becoming a widespread concern
around the world regardless of the latitude. Serum 25-
hydroxy vitamin D (S-25-OHD) concentration, which is
the best indictor of vitamin D status, has been shown to
decrease in elderly Finnish women in winter [20,21]. It has
been estimated that ambulatory elderly women require on
average 18 μg vitamin D per day to maintain adequate
vitamin D level (that is, S-25-OHD above 50 nmol/L) dur-
ing winter. Inadequate intakes of vitamin D and calcium
lead to reduced calcium absorption, higher bone turnover
and increased bone loss and risk of fractures [22-25]. Even
more important may be the finding that S-25-OHD level
is inversely associated with falls [24,26-28]. In randomized
controlled trials the incidence of falls was almost halved
and musculoskeletal function improved among elderly
people with a combination of vitamin D and calcium com-
pared with calcium supplement alone [29,30]. Falling may,
at least partly, be a consequence of impaired neuromuscu-
lar function associated with vitamin D deficiency, since
abnormal motor performance, increased body sway, and
quadriceps weakness have been reported in those with low
vitamin D status. Vitamin D receptors are known to be
present in muscle tissue. Furthermore, the number of fast
type II muscle fibers decreases with age, and these fibers
are the first to be recruited in balance perturbation to
avoid falling [31,32].
In prevention of fractures of elderly people, the focus
should be shifted from treating low BMD to improving
muscle strength and the neuromuscular co-ordination
to avoid falls, since most fractures are a direct conse-
quence of falling [33]. Although a recently published
metaanalysis found little evidence that current multifac-
torial falls prevention programs could prevent falls and
related injuries [34], it must be kept in mind that a
great majority of fall-prone elderly adults has more than
one risk factor for falls. Furthermore, fear of falling may
restrict habitual physical activity and lead to declined
functional ability [19,35,36].
As noted above, randomized controlled trials suggest
that exercise may effectively improve many factors
affecting falling, such as muscle strength, flexibility, bal-
ance, coordination, proprioception, reaction time and
gait [37-41]; thus reducing the risk of falling [3,7-9,42].
Regular moderate to vigorous exercise is also associated
with reduced number of fractures [18,43,44]. Also vita-
min D has been proposed to protect against falls and
fractures [27]. Thus, it is well justified to study the sepa-
rate and combined effects of exercise and vitamin D in
prevention of falls and related injuries.
Although there is evidence that both exercise and vita-
min D by themselves can benefit neuromuscular and
cognitive function, and thus contribute to reduced risk
of falls; these two factors have not previously been eval-
uated in combination. In this paper, we describe the
design of such a study.
Methods/Design
Study aims, design and setting
The present study is a four-arm randomized, double-
blind placebo-controlled vitamin D and open exercise
intervention trial where community-dwelling, indepen-
dently living Finnish women aged 70 to 80 years are
randomized to receive either vitamin D 800 IU (20 μg/
d) or placebo, and to participate in either supervised
exercise or non-exercise group for 24 months (DEX
study).
The primary aim of this study is to investigate the
effects of exercise and vitamin D supplementation, alone
or in combination, on reducing falls and fall-related
injuries.
Ethical consideration
The study protocol has been approved by the Ethics
Committee of the Tampere University Hospital, Tam-
pere, Finland (R09090). Each participant provided her
written informed consent prior to randomization. The
study protocol is registered in the ClinicalTrial.gov -
register (NCT00986466).
Outcomes
The primary outcome of the study is the rate of falls
and fall-related injuries. Changes in neuromuscular
functioning (e.g. body balance, muscle strength), ADL-
and mobility functions, bone health, fractures, cardiovas-
cular risk factors, health-related quality of life, fear of
falling, depression (WHO-5), cognition (Mini-mental
State examination, MMSE) and rate of institutionaliza-
tion will be analyzed as the secondary outcomes.
Uusi-Rasi et al. BMC Geriatrics 2012, 12:12
http://www.biomedcentral.com/1471-2318/12/12
Page 2 of 7
Sample size consideration
The sample size and power calculations have been esti-
mated for the primary outcome of this study, i.e., the
rate of falls. We hypothesized that there will be a 30%
difference in the rate of falls between the treatment
groups (vitamin D vs. placebo, and exercise vs. non-
exercise). The number of women in each group is based
on the expectation that the intervention programme
(exercise or vitamin D treatment) will reduce the inci-
dence rate of falls by 30% during the two years interven-
tion and the between-group difference will be detected
for a given significance level of 0.05 with a statistical
power of 80% with a mean treatment time of 1.5 years.
The baseline incidence was assumed to be 67 falls per
100 person-years. Accordingly 260 participants needed
to be recruited into the study (130 exercisers and 130
non-exercisers, 65 in each group with vitamin D supple-
ment). However, in order to eliminate the role of chance
in detecting the possible interaction of vitamin D and
exercise, a total number of 400 subjects (100 subjects in
each group) were recruited into the study.
Screening for inclusion
Flowchart of the trial is shown in Figure 1. All 70 to 80-
year old women living in the city of Tampere, Finland
(n = 9370) were invited to participate in the trial. In
addition to willingness, history of at least one fall during
the last 12 months and no regular use of vitamin D sup-
plements were the two other primary criteria mentioned
in the first contact letter.
A pre-screening Health history questionnaire (informa-
tion of self-reported health, previous falls, injuries, medi-
cation, diseases, and life style factors such as diet,
physical activity, smoking and consumption of alcohol)
was mailed to 1213 (12.9%) responders who expressed
their initial interest and 433 women initially considered
eligible for the study were then invited to the medical
examination. The inclusion criteria were age between
70-80 years, living at home independently; had fallen at
least once during the previous year; no contraindication
to exercise; understands the procedures of the study,
has been informed of X-ray radiation doses of the DXA
and pQCT investigations, and amount of blood samples
needed, and voluntarily agrees to undergo all measure-
ments and signs informed consent prior to beginning of
the procedure. The exclusion criteria were moderate to
vigorous exercise more than 2 hours per week; regular
use of vitamin D or calcium + vitamin D supplements; a
recent fracture (during preceding 12 months); contrain-
dication or inability to participate in the exercise pro-
gram; a marked decline in the basic activities of daily
living (ADL); cognitive impairments (Mini Mental State
Examination, MMSE-test); primary hyperthyroidism;
and degenerative conditions, such as Parkinson’s disease.
A physician excluded 16 additional women due to
exclusion criteria, and 8 withdrew after the baseline
measurements leaving 409 eligible women for
randomization.
Randomization
409 participants were randomly assigned into one of the
four arms using a computer-generated randomization
list (based on simple randomization with random alloca-
tion sequence to ensure equal group sizes). The four
arms are: 1) exercise + vitamin D (800 IU/d) 2) exercise
+ placebo 3) no exercise + vitamin D (800 IU/d) 4) no
exercise + placebo.
Participant follow-up procedures
Falls
The number of falls will be monitored with daily fall
diaries. Diaries will be collected monthly through the
mail. Details of each registered fall will be ascertained
by the investigator. The definition of a fall is “an unex-
pected event in which the participant come to rest on
the ground, floor or lower level” [45]. Injurious falls are
those requiring medical attention and treatment. Minor
injuries, such as bruises, edemas, muscular or joint pain,
will also be recorded.
Measurements
All measurements will be done at baseline, at 12-, and
24-month (the end point of the intervention). Blood
samples and physical functioning will be assessed also at
6, and 18-month time points.
General health status and falls consequences
Information on the participant’s health, medication, life-
style (level of physical activity, use of alcohol, smoking),
mobility and cognitive functions will be assessed with
appropriate methods. The methods to evaluate func-
tional ability, health-related quality of life (Leipad, Fin-
nish version), fear of falling (Falls Efficacy Scale-
International, FES-I, Finnish version) and physical activ-
ity (CHAMPS -activities questionnaire for older people)
are modified suitable for the Finnish culture.
Anthropometry
Body height will be measured to the nearest 0.1 cm, and
body weight to the nearest 0.1 kg with a high-precision
scale. Body composition (fat mass and lean body mass)
will be assessed with dual-energy X-ray absorptiometry
(DXA, Lunar Prodigy Advance, GE Lunar, Madison, WI,
USA). According to repeated measurements of 22
adults, the in vivo precision (coefficient of variation, CV
%) was 1.3% for fat mass and 0.7% for fat-free lean mass
(Sievänen, unpublished).
Bone measurements
Bone mineral content (BMC) of the total body, lumbar
spine and left proximal femur (femoral neck and
Uusi-Rasi et al. BMC Geriatrics 2012, 12:12
http://www.biomedcentral.com/1471-2318/12/12
Page 3 of 7
trochanter) will be assessed using dual-energy X-ray
absorptiometry (DXA) (Lunar Prodigy Advanced, GE
Lunar, Madison, WI, USA). At our laboratory, the in
vivo day-to-day precision (coefficient of variation, CV%)
of the DXA scanning is better than 1% for the lumbar
spine and 1.5% for the proximal femur (Sievänen 2005,
unpublished). In addition to bone mass, strength of the
femoral neck will be estimated from the DXA-measure-
ments using the AHA-software.
In addition to the DXA measurements, the tibia will
be measured with peripheral quantitative computed
tomography (pQCT) (Norland/Stratec XCT 3000, Pforz-
heim, Germany). The tomographic slices will be taken
from the midshaft (50%) and distal part (5% of the tibial
length from the distal end plate of the tibia) for asses-
sing bone mineral mass, cortical and trabecular apparent
densities as well as strength traits of this weight-bearing
bone [46].
Figure 1 Flowchart of the randomized control trial.
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Physical performance, physical functioning, and physical
activity
The maximal isometric leg-extensor strength at the knee
ankle 110° will be measured by a strain gauge dynam-
ometer (Tamtron, Tampere, Finland) and the grip
strength of both forearms with a standard hand dynam-
ometer (Lafaytte, Loughborough, UK). The participants
are verbally encouraged to perform to their maximum
and the best performance from three trials will be taken
as a test result. Timed up and go test (TUG) [47], Short
Physical Performance Battery (SPPB) [48,49] and back-
wards walking [50,51] will be used for assessing physical
functioning. In addition to CHAMPS, each participant’s
daily number of steps will be measured with a ped-
ometer (Omron HJ-112-E) over the entire 24-month
study period.
Vitamin D status
Dietary intake of calcium and vitamin D will be assessed
with a validated food frequency questionnaire [52] and
calculated by Micro-Nutrica software (Social Insurance
Institution, Helsinki, Finland). Serum 25-hydroxy-vita-
min D (S-25-OHD) will be measured as a marker of
vitamin D-metabolism with an OCTEIA immunoenzy-
mometric assay (IDS, Bolton, UK). In addition, serum
intact parathyroid hormone (S-iPTH) will be measured
(OCTEIA, IDS), as it usually increases when S-25OHD
is low, and gives additional information on the severity
of vitamin D deficiency. Genomic DNA sample will be
taken to find possible gene polymorphism associated
with vitamin D metabolism (e.g. the vitamin D receptor,
VDR).
Plan of analysis
The incidence rate will be calculated as the number of
falls divided by the time over which falls are monitored
for each participant. The data will be analyzed as a 2 ×
2 factorial design and Poisson regression models will be
used to estimate incidence rate ratio between the two
exercise groups and between the two vitamin D groups
for falls and injuries falls. Between-group changes in
neuromuscular functioning, physical ability, bone traits,
and quality of life will be analyzed by analysis of covar-
iance (ANCOVA) or logistic regression analysis.
Intervention
Vitamin D supplements/placebo
The participants were randomly assigned to receive pla-
cebo (50% of the participants) or 800 IU (20 μg) of vita-
min D (50% of the participants) per day for two years.
Both participants and outcome assessors are blinded to
the group assignment of placebo or vitamin D during
the study. At the start, each participant received a pack
of pills for six months, and when arriving to the follow-
up measurements at six-month intervals the used packs
will be returned and new full packs will be given. At
this time, compliance will be confirmed by remaining
pill counts. A questionnaire on side effects will be admi-
nistered to all participants at six-month intervals to
monitor safety. As standard safety markers, S-Ca and S-
Pi will be assayed.
Training program
Participants randomized to the exercise groups (50% of
the participants either on vitamin D or placebo) will
attend supervised training classes 2 times a week for the
first 12 months, and once a week for the last 12 months
of the 24-month intervention. In addition, they receive a
home exercise plan to be practised on the rest days.
All group training sessions are supervised by 1 or 2
experienced exercise leaders (physiotherapists). The
training program is progressive and consists of strength,
balance, agility and mobility training. Main components
of the exercise program has been found safe and feasible
in the present age group in our previous study [38].
Training sessions are carried out in 8-week periods,
either in the exercise hall or gym. Around 10 to 20 par-
ticipants are expected to attend these training sessions.
All training sessions last 60 minutes and include a 10
minutes warm-up as well as stretching for major muscle
groups. A 4-week familiarizing period precedes the first
8-week training period to accustom the exercisers to the
training, and to familiarize them to each other and the
exercise leaders.
During the group exercises in hall, exercises focusing
on balance, agility, mobility and change of direction are
emphasized. Different surfaces and dual-task situations
are employed, especially in balance and agility exercises.
In addition to own body weight, ankle weights and vest
weights are used in muscle strength exercises. Some
exercises will be done with a chair (especially at the
beginning of the training) or with a step-board (when
advanced). The advanced programs are also aerobic in
nature. Exercise programs will either be led by the lea-
ders or implemented as supervised circuit training. Exer-
cise leaders keep a record of the participants’ attendance
at the group training sessions.
During the gym exercises, resistive equipment is used.
All programs include 8-9 different exercises focusing on
strengthening large muscle groups: leg extensors (leg
press), hip extensors, hip abductors, knee extensors,
knee flexors, calf muscles, back muscles, and shoulder
and arm muscles. The first gym period begins with 30 -
60% of one repetition maximum (1RM). The target level
progresses to 60-75% of 1RM. Two sets of each exercise
are done, each set consisting of 8-12 repetitions. The
intensity of strength training is assessed using rated per-
ceived exertion (RPE) [53]. The target RPE ranges from
14-18 (12 when starting), and advances progressively.
Balance training is included in a short warm-up period.
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In addition to supervised training sessions, the exerci-
sers have a home-training program modified from the
exercises used during training sessions. During the first
year the participants are guided to train at home in the
days they do not participate in the supervised group
training. In the second year, home-training sessions are
recommended at least 3 times a week. One home train-
ing session requires 5 to 15 minutes. The exercisers
keep a home training diary.
The participants in the non-exercising group (50% of
the participants either on vitamin D or placebo) are
asked to maintain their current level of physical activity.
Time schedule
Preparations for recruitment of the participants were
completed during the spring 2009. The screening and
baseline measurements of the participants began in fall
2009. For practical reasons, the trial started in two
phases (201 participants in March 2010 and 208 in
March 2011), the follow-up measurements will be car-
ried out in spring 2012 and 2013, respectively.
Discussion
At the time of writing, recruitment was completed and
all participants had been randomized and respective
interventions started as planned. The 24-month mea-
surements and the follow-up of the first group will be
completed in March 2012, and the second group in
March 2013. Results will be available late 2013.
Although it is not possible to comment on the effective-
ness of the intervention, it is evident that the partici-
pants are well committed to the study.
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